Ontogeny of complement regulatory proteins - Concentrations of factor H, factor I, C4b-binding protein, properdin and vitronectin in healthy children of different ages and in adults

被引:53
作者
de Paula, PF
Barbosa, JE
Junior, PR
Ferriani, VPL
Latorre, MRDO
Nudelman, V
Isaac, L
机构
[1] Univ Sao Paulo, Inst Ciencias Biomed, Dept Imunol, BR-05508900 Sao Paulo, Brazil
[2] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, BR-05508900 Sao Paulo, Brazil
[3] Univ Sao Paulo, Dept Pediat, Fac Med Ribeirao Preto, BR-05508900 Sao Paulo, Brazil
[4] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
关键词
D O I
10.1046/j.1365-3083.2003.01326.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies of human in vivo complement protein levels have only compared data for neonates with that from adult sera. Here, we establish the normal concentration ranges of the following complement regulatory proteins in healthy Brazilian children of different age groups (neonates: 1 month-1 year, 1-6 years and 6-13 years) and in adults: factor H (fH), factor I (fI), C4b-binding protein (C4 BP), properdin and vitronectin. We found that the concentrations of fH, fI, properdin and vitronectin in neonates are significantly lower than in adults. Remarkably, the concentration of C4 BP is below the method resolution (<50 mug/ml) in 76% of the sera from neonates, while adults presented 199-532 mug/ml of C4 BP in their sera. The concentration of properdin in the sera from neonates and up to 1-year-old children was less than that observed in older children. Adults presented vitronectin levels significantly higher than all the other age groups in the study. No significant sex differences in the concentrations of all the studied regulatory proteins were detected. This study reveals the ontogeny of complement system in greater detail than previously available and may point to the reasons why neonates have higher susceptibility to develop life-threatening pyogenic infections. These reference values will be of use in clinical and laboratory investigations of disorders associated with low levels of these regulatory proteins.
引用
收藏
页码:572 / 577
页数:6
相关论文
共 35 条
  • [11] HARARI DK, 2002, REV PAUL PEDIAT, P37
  • [12] HEALY MJR, 1969, ANN CLIN BIOCHEM, V6, P12
  • [13] HULLEY SB, 1988, DESIGNING CLIN RES E, P219
  • [14] INVITRO BIOSYNTHESIS OF COMPLEMENT FACTOR-I BY HUMAN ENDOTHELIAL-CELLS
    JULEN, N
    DAUCHEL, H
    LEMERCIER, C
    SIM, RB
    FONTAINE, M
    RIPOCHE, J
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (01) : 213 - 217
  • [15] INTERFERON-INDUCED TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL MODULATION OF FACTOR-H AND C4-BINDING-PROTEIN SYNTHESIS IN HUMAN MONOCYTES
    LAPPIN, DF
    WHALEY, K
    [J]. BIOCHEMICAL JOURNAL, 1990, 271 (03) : 767 - 772
  • [16] GENETIC DEFICIENCIES OF COMPLEMENT
    LOKKI, ML
    COLTEN, HR
    [J]. ANNALS OF MEDICINE, 1995, 27 (04) : 451 - 459
  • [17] Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2
  • [18] LEVELS AND PLASMA DISTRIBUTION OF FREE AND C4B-BP-BOUND PROTEIN-S IN HUMAN FETUSES AND FULL-TERM NEWBORNS
    MOALIC, P
    GRUEL, Y
    BODY, G
    FOLOPPE, P
    DELAHOUSSE, B
    LEROY, J
    [J]. THROMBOSIS RESEARCH, 1988, 49 (05) : 471 - 480
  • [19] Morley B, 2000, The complement facts Book
  • [20] Deficiency of human complement factor I associated with lowered factor H
    Naked, GM
    Florido, MPC
    de Paula, PF
    Vinet, AM
    Inostroza, JS
    Isaac, L
    [J]. CLINICAL IMMUNOLOGY, 2000, 96 (02) : 162 - 167